{"url_path":"/sec/pbh/8-k/2026-06-16/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-16","source_url":"https://www.sec.gov/Archives/edgar/data/1295947/0001104659-26-074259-index.html","accession_number":"0001104659-26-074259","cik":"0001295947","ticker":"PBH","issuer_name":"Prestige Consumer Healthcare Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1295947/0001104659-26-074259-index.html","primary_entity_key":"0001295947","primary_entity_name":"Prestige Consumer Healthcare Inc."},"word_count":56,"has_tables":true,"body_markdown":"** **\n\n**Item 8.01 Other Events.**\n\n \n\nOn June 15, 2026, the Company\nissued a press release announcing the Company’s entry into the Term Loan Credit Agreement, the ABL Amendment and the completion\nof the Transaction. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and incorporated herein\nby reference."}